STOCK TITAN

Director George Parmer buys 731,706 Amesite (NASDAQ: AMST) securities in placement

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Amesite Inc. director George Parmer reported a net purchase of Amesite securities. He bought 243,902 shares of Common Stock at $1.435 per share in a private placement pursuant to a securities purchase agreement. Following this, he directly holds 566,962 Common shares.

Parmer also acquired 243,902 Series A-2 Warrants and 243,902 Series A-1 Warrants, each giving the right to buy Common Stock at an exercise price of $1.435 per share. The Series A-2 Warrants expire on October 28, 2027, and the Series A-1 Warrants expire on April 28, 2031. These transactions were made in connection with the same private placement offering described in an Amesite 424(b)(5) prospectus supplement.

Positive

  • None.

Negative

  • None.
Insider Parmer George
Role null
Bought 731,706 shs ($350K)
Type Security Shares Price Value
Purchase Series A-1 Warrants (right to buy) 243,902 $0.00 --
Purchase Series A-2 Warrants (right to buy) 243,902 $0.00 --
Purchase Common Stock 243,902 $1.435 $350K
Holdings After Transaction: Series A-1 Warrants (right to buy) — 243,902 shares (Direct, null); Series A-2 Warrants (right to buy) — 243,902 shares (Direct, null); Common Stock — 566,962 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Common shares purchased 243,902 shares Common Stock bought on April 28, 2026
Purchase price per share $1.435 per share Price for Common Stock in private placement
Common shares held after 566,962 shares Direct Common Stock ownership after transaction
Series A-2 Warrants acquired 243,902 warrants Right to buy Common Stock at $1.435
Series A-1 Warrants acquired 243,902 warrants Right to buy Common Stock at $1.435
Series A-2 Warrant expiration October 28, 2027 Expiration date for Series A-2 Warrants
Series A-1 Warrant expiration April 28, 2031 Expiration date for Series A-1 Warrants
Total securities bought (Form 4 summary) 731,706 shares Net buy across Common and warrant-related shares
private placement financial
"The shares were purchased in a private placement transaction pursuant to a securities purchase agreement."
A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.
securities purchase agreement financial
"The shares were purchased in a private placement transaction pursuant to a securities purchase agreement."
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
424(b)(5) prospectus supplement regulatory
"please refer to the 424(b)(5) prospectus supplement filed by Amesite Inc. with the SEC on April 28, 2026."
Series A-2 Warrants financial
"Series A-2 Warrants (right to buy) ... underlying security title: Common Stock"
Series A-2 warrants are a specific class of long‑term options issued by a company that give the holder the right to buy a set number of shares at a pre‑agreed price. Think of them as a coupon for future stock purchases: they can add potential value for the holder if the share price rises, but they also represent potential dilution for existing shareholders and can affect an investor’s ownership and returns when exercised or converted.
Series A-1 Warrants financial
"Series A-1 Warrants (right to buy) ... underlying security title: Common Stock"
Series A-1 warrants are tradable instruments that give their holder the right, but not the obligation, to buy a company’s shares at a preset price for a limited time; they are typically issued alongside a specific financing round labeled “Series A-1.” Think of them like a coupon that lets an investor buy stock at a locked-in price later — if the company’s share price rises above that price the coupon becomes valuable, otherwise it may expire worthless. For investors they matter because exercising warrants can increase potential upside while also diluting existing shareholders and affecting future ownership percentages and share value.
open-market purchase financial
"transaction_action: open-market purchase; transaction_code_description: Purchase in open market or private transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Parmer George

(Last)(First)(Middle)
C/O AMESITE INC.
607 SHELBY STREET, SUITE 700 PMB 214

(Street)
DETROIT MICHIGAN 48226

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Amesite Inc. [ AMST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/28/2026P243,902A$1.435(1)566,962D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series A-1 Warrants (right to buy)$1.43504/28/2026P243,90204/28/202604/28/2031Common Stock243,902$0243,902D
Series A-2 Warrants (right to buy)$1.43504/28/2026P243,90204/28/202610/28/2027Common Stock243,902$0243,902D
Explanation of Responses:
1. The shares were purchased in a private placement transaction pursuant to a securities purchase agreement. For more information relating to the offering pursuant to which the reported shares were purchased, please refer to the 424(b)(5) prospectus supplement filed by Amesite Inc. with the SEC on April 28, 2026.
/s/ Ann Marie Sastry Ph.D., as Attorney-in-Fact05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Amesite (AMST) director George Parmer buy in this Form 4 filing?

George Parmer bought Common Stock and related warrants in Amesite. He purchased 243,902 Common shares at $1.435 per share and received matching Series A-1 and A-2 Warrants for 243,902 underlying shares each in a private placement transaction.

How many Amesite (AMST) shares does George Parmer own after these transactions?

After these transactions, George Parmer directly owns 566,962 Amesite Common shares. This reflects the newly purchased 243,902 shares added to his prior holdings, as disclosed in the Form 4, and does not include shares underlying the newly acquired warrants.

What are the key terms of the Amesite (AMST) Series A-1 and A-2 Warrants?

Parmer acquired 243,902 Series A-1 and 243,902 Series A-2 Warrants, each exercisable for Common Stock at $1.435 per share. The Series A-2 Warrants expire on October 28, 2027, while the Series A-1 Warrants have a longer term, expiring on April 28, 2031.

Was the Amesite (AMST) insider purchase an open-market trade or private placement?

The purchase occurred in a private placement transaction under a securities purchase agreement. The footnote explains the shares and warrants were acquired in an offering described in Amesite’s 424(b)(5) prospectus supplement filed with the SEC on April 28, 2026.

How many Amesite (AMST) securities did George Parmer buy in total?

Across Common Stock and warrants, the Form 4 shows net purchases of 731,706 Amesite-related securities. This includes 243,902 Common shares plus 243,902 underlying shares for each of the Series A-1 and Series A-2 Warrants acquired in the private placement.